COVID-19: not the time for health economists? A plea for more proactive health economic involvement

por Schulenburg, J.-Matthias Graf von der
Publicado 2021

Greetings from the Editors

por Graf von der Schulenburg, J-Matthias, Braun, Sebastian
Publicado 2011

Benefit assessment in Germany: implications for price discounts

por Theidel, Ulrike, von der Schulenburg, J-Matthias Graf
Publicado 2016

Dividend policy issues in the European pharmaceutical industry: new empirical evidence

por Basse, Tobias, Schwarzbach, Christoph, Graf von der Schulenburg, J.-Matthias
Publicado 2022

Measuring economic consequences of preterm birth - Methodological recommendations for the evaluation of personal burden on children and their caregivers

por Hodek, Jan-Marc, von der Schulenburg, J-Matthias, Mittendorf, Thomas
Publicado 2011

Promoting vaccinations - an analysis of measures taken by German statutory health insurers

por Damm, Kathrin, Schubert, Jana M, von der Schulenburg, J-Matthias
Publicado 2011

Valuation of the EQ-5D-5L with composite time trade-off for the German population – an exploratory study

por Ludwig, Kristina, von der Schulenburg, J.-Matthias Graf, Greiner, Wolfgang
Publicado 2017

German Value Set for the EQ-5D-5L

por Ludwig, Kristina, Graf von der Schulenburg, J.-Matthias, Greiner, Wolfgang
Publicado 2018

Patient-reported data informing early benefit assessment of rare diseases in Germany: A systematic review

por Babac, Ana, Damm, Kathrin, Graf von der Schulenburg, J.-Matthias
Publicado 2019

Note from the editor, January 2021

por von der Schulenburg, J.-Matthias Graf, Braun, Sebastian, Zeidler, Jan
Publicado 2021

Cost effectiveness of ulcerative colitis treatment in Germany: a comparison of two oral formulations of mesalazine

por Prenzler, Anne, Yen, Linnette, Mittendorf, Thomas, von der Schulenburg, J-Matthias
Publicado 2011

Early benefit assessment (EBA) in Germany: analysing decisions 18 months after introducing the new AMNOG legislation

por Ruof, Jörg, Schwartz, Friedrich Wilhelm, Schulenburg, J.-Matthias, Dintsios, Charalabos-Markos
Publicado 2013

Impact of radiofrequency ablation for patients with varicose veins on the budget of the German statutory health insurance system

por Kuhlmann, Alexander, Prenzler, Anne, Hacker, Jan, Graf von der Schulenburg, J-Matthias
Publicado 2013

Genome sequencing: a systematic review of health economic evidence

por Frank, Martin, Prenzler, Anne, Eils, Roland, Graf von der Schulenburg, J-Matthias
Publicado 2013

The Role of decision-analytic modelling in German health technology assessments

por Kuhlmann, Alexander, Treskova, Marina, Braun, Sebastian, Graf von der Schulenburg, J-Matthias
Publicado 2015

Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany

por Kuhlmann, Alexander, Theidel, Ulrike, Pletz, Mathias W, von der Schulenburg, J-Matthias Graf
Publicado 2012

Measuring patients’ priorities using the Analytic Hierarchy Process in comparison with Best-Worst-Scaling and rating cards: methodological aspects and ranking tasks

por Schmidt, Katharina, Babac, Ana, Pauer, Frédéric, Damm, Kathrin, von der Schulenburg, J-Matthias
Publicado 2016

Costs and treatment patterns of incident ADHD patients - a comparative analysis before and after the initial diagnosis -

por Klora, Mike, Zeidler, Jan, Linder, Roland, Verheyen, Frank, von der Schulenburg, J.-Matthias Graf
Publicado 2015

Applying the Analytic Hierarchy Process in healthcare research: A systematic literature review and evaluation of reporting

por Schmidt, Katharina, Aumann, Ines, Hollander, Ines, Damm, Kathrin, von der Schulenburg, J.-Matthias Graf
Publicado 2015

A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)

por Lange, Ansgar, Prenzler, Anne, Frank, Martin, Golpon, Heiko, Welte, Tobias, von der Schulenburg, J-Matthias
Publicado 2014